Filtros de búsqueda

Lista de obras de Miguel Quintela-Fandino

18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.

artículo científico publicado en 2016

Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance

artículo científico publicado en 2016

Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality

artículo científico publicado en 2016

Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase Inhibitors.

artículo científico publicado en 2016

Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.

artículo científico publicado en 2006

CX3CL1 promotes breast cancer via transactivation of the EGF pathway

artículo científico publicado en 2013

Coexistence of two rare sarcomas: primary leiomyosarcoma of bone and epithelioid hemangioendothelioma of the liver.

artículo científico publicado en 2008

Critically short telomeres and toxicity of chemotherapy in early breast cancer

artículo científico publicado en 2017

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.

artículo científico publicado en 2006

Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets.

artículo científico publicado en 2009

Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells

scientific article published on 01 November 2019

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial

artículo científico publicado en 2020

In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours.

artículo científico publicado en 2013

In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer

artículo científico publicado en 2018

Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET.

artículo científico publicado en 2015

Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

artículo científico publicado en 2019

Normoxic or hypoxic adaptation in response to antiangiogenic therapy: Clinical implications.

artículo científico publicado en 2016

Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach

artículo científico publicado en 2017

Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).

artículo científico publicado en 2014

Phase I combination of sorafenib and erlotinib therapy in solid tumors: safety, pharmacokinetic, and pharmacodynamic evaluation from an expansion cohort

artículo científico publicado en 2010

Phase II trial of vinorelbine tartrate in patients with treatment-naive metastatic melanoma.

artículo científico publicado en 2005

Prediction of response to targeted therapies in lung cancer using dynamic imaging: still far from clinical implementation.

artículo científico publicado en 2011

Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer

artículo científico publicado en 2019

Revisiting the Revolution: Examining the Evolving Role of Antiangiogenic Therapy in Cancer

artículo científico publicado en 2016

Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trial ⬇️

artículo científico publicado en 2014

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

artículo científico publicado en 2016

Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics.

artículo científico publicado en 2016

Targeting cytoskeleton reorganisation as antimetastatic treatment.

scientific article published on October 2010

The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk ⬇️

artículo científico publicado el 18 de julio de 2011

Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer.

artículo científico publicado en 2017

Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

artículo científico publicado en 2006

[Severe metabolic acidosis in a patient treated with trimethoprim-sulfamethoxazole. Physiopathological facts]

scientific article published on 01 August 2003

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda